Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | NPC1 | O15118 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4062151 | 0.88 | HSP90AA1 (0.48) | HSP90AA1KDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL15413264 | 0.86 | KDM4E (0.45) | KDM4ENPC1ALDH1A1KMT2AMEN1 | |
| SCHEMBL24866746 | 0.83 | KDM4E (0.43) | KDM4ENPC1ALDH1A1KMT2AMEN1 | |
| SCHEMBL31164464 | 0.83 | KDM4E (0.43) | KDM4ENPC1ALDH1A1KMT2AMEN1 | |
| SCHEMBL30064908 | 0.80 | NPC1 (0.50) | HSP90AA1KDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL22208087 | 0.80 | NPC1 (0.50) | HSP90AA1KDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL4104185 | 0.80 | NPC1 (0.50) | HSP90AA1KDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL30065042 | 0.80 | NPC1 (0.50) | HSP90AA1KDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL4766494 | 0.79 | ALDH1A1 (0.46) | HSP90AA1KDM4ENPC1RAB9AALDH1A1 | |
| SCHEMBL4072123 | 0.78 | ALDH1A1 (0.57) | KDM4ENPC1RAB9AALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008116816-A1 | COMBINATION OF CB2 LIGAND AND PARACETAMOL | GLAXO GROUP LIMITED (GB) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008116816-A1 | COMBINATION OF CB2 LIGAND AND PARACETAMOL | GLAXO GROUP LIMITED (GB) | 2008-10-02 | — | — | WO | disclosed |
| US-20080221097-A1 | Imidazopyridine Derivatives as Cannabinoid Receptor Ligands | GLAXO GROUP LIMITED | 2008-09-11 | — | — | US | disclosed |
| US-20080221097-A1 | Imidazopyridine Derivatives as Cannabinoid Receptor Ligands | GLAXO GROUP LIMITED | 2008-09-11 | — | — | US | disclosed |
| US-20080221097-A1 | Imidazopyridine Derivatives as Cannabinoid Receptor Ligands | GLAXO GROUP LIMITED | 2008-09-11 | — | — | US | disclosed |
| EP-1912985-A1 | IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007017237-A1 | IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2007-02-15 | — | — | WO | disclosed |
| WO-2007017237-A1 | IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS | GLAXO GROUP LIMITED (GB) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221097-A1 | Imidazopyridine Derivatives as Cannabinoid Receptor Ligands | CNR1, CNR2, TRPV1 | HSP90AA1 2792/4885KDM4E 2327/4885NPC1 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.